Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $3.2 million.

  • Nephros' Total Liabilities rose 4651.9% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 4651.9%. This contributed to the annual value of $2.6 million for FY2024, which is 2506.42% down from last year.
  • Per Nephros' latest filing, its Total Liabilities stood at $3.2 million for Q3 2025, which was up 4651.9% from $2.6 million recorded in Q2 2025.
  • Nephros' Total Liabilities' 5-year high stood at $3.5 million during Q4 2023, with a 5-year trough of $1.7 million in Q2 2023.
  • Over the past 5 years, Nephros' median Total Liabilities value was $2.5 million (recorded in 2025), while the average stood at $2.5 million.
  • In the last 5 years, Nephros' Total Liabilities crashed by 4849.72% in 2021 and then skyrocketed by 8336.22% in 2024.
  • Over the past 5 years, Nephros' Total Liabilities (Quarter) stood at $2.9 million in 2021, then decreased by 26.99% to $2.1 million in 2022, then skyrocketed by 65.39% to $3.5 million in 2023, then fell by 25.06% to $2.6 million in 2024, then rose by 23.47% to $3.2 million in 2025.
  • Its Total Liabilities was $3.2 million in Q3 2025, compared to $2.6 million in Q2 2025 and $2.5 million in Q1 2025.